SEC Form 4 research
| Issuer | OKYO Pharma Ltd |
|---|---|
| Tickers | OKYO |
| Reporting owners | 10 |
| Officers and directors | 3 |
| Last public filing | 2026-08-08 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-07 | 2026-07-21 | BRANCACCIO JOHN P | P | 5,000 | $1.48 | Not reported |
| 2026-08-07 | 2026-07-22 | Dempsey Robert John | P | 15,000 | $1.54 | Not reported |
| 2026-08-07 | 2026-07-21 | JACOB GARY S | P | 3,500 | $1.4 | Not reported |
| 2026-08-07 | 2026-07-20 | CERRONE GABRIELE M | P | 25,000 | $1.4 | Not reported |
| 2026-08-07 | 2026-07-27 | Patil Rajkumar V. | P | 3,363 | $1.49 | Not reported |
| 2026-08-07 | 2026-07-21 | Mantelli Flavio | P | 20,000 | $1.4 | Not reported |
| 2026-08-07 | 2026-07-21 | CERRONE GABRIELE M | P | 22,500 | $1.45 | Not reported |
| 2026-07-29 | 2026-07-27 | Patil Rajkumar V. | A | 3,363 | $1.49 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.